“PI3K/mTOR dual kinase inhibitor XL765”的概念、定义、翻译、参考文献-科学参考

An orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in susceptible tumor cell populations. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion in response to nutrient and energy deprivation. Accordingly, this agent maybe more potent compared to an agent that inhibits either PI3K kinase or mTOR kinase alone.

单词	PI3K/mTOR dual kinase inhibitor XL765
释义	PI3K/mTOR dual kinase inhibitor XL765 An orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in susceptible tumor cell populations. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion in response to nutrient and energy deprivation. Accordingly, this agent maybe more potent compared to an agent that inhibits either PI3K kinase or mTOR kinase alone.
随便看	indinavir sulfate indirect ophthalmoscopy Indium 111 ProstaScint indium In 111 anti-CD45 monoclonal antibody BC8 indium In 111 anti-CEA monoclonal antibody M5A indium In 111 anti-EGFR monoclonal antibody ABT-806 indium In 111 bevacizumab indium In 111 capromab pendetide indium In 111 chimeric monoclonal antibody 806 indium In 111 CHX-A DTPA trastuzumab indium In 111 CHX-A DTPA trastuzumab indium In 111-CMD-193 indium In 111-DOTA-biotin indium In-111-DOTA-di-HSG peptide IMP-288 indium In 111-DOTA-exendin-4 indium In 111-DOTA-girentuximab indium In 111 ibritumomab tiuxetan indium In 111-labeled autologous peripheral blood mononuclear cells indium In 111-labeled autologous polymorphonuclear leukocytes indium In 111 monoclonal antibody BrE-3 indium In 111 monoclonal antibody huPAM4 indium In 111 pentetate indium In 111 pentetreotide indium In 111 pertuzumab individualized education plan